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synthesis is asymmetric, the action of this transporter defeats vectoral biosynthesis and results in a more random distribution of lipids across the bilayer.
Sphingolipids are localized predominately on the external leaflet of the plasma membrane. Unlike PC synthesis, sphingolipid synthesis occurs predominantly on the side of the membrane in which these lipids ultimately reside. With the exception of glucosylceramide (Glc-Cer), which is synthesized on the cytofacial side of the Golgi, all of the sphingolipids are synthesized on the lumenal surface of the ER or Golgi, including sphingomyelin, galactosylceramide and complex sugar-linked sphingolipids (7, 32, 33) .
Because Glc-Cer is a precursor of many glycosylsphingolipids, a mechanism must exist to transport this lipid to the lumenal surface of the ER or Golgi. A transporter that catalyzes the transbilayer movement of short chain analogs of Glc-Cer has been discovered (34, 35) that may server this function.
The selective accumulation of glycerophospholipids on one side of the plasma membrane requires that during, or as a result of, membrane trafficking from the ER to the plasma membrane that the transbilayer randomizing process be inhibited or that an asymmetry-generating process be activated. Thermodynamic considerations require an input of energy to generate, or to maintain, a transbilayer lipid gradient. Consistent with these needs, both inward-and outward ATP-dependent lipid transport activities have been discovered that selectively move lipids, across the plasma membrane. The asymmetric distribution of phospholipids in the plasma membrane may be the result of the selective trafficking or regulation of lipid transporting proteins. The retention of ATP-independent non-selective lipid transporters in the ER, combined with the trafficking of substrate-specific ATP-dependent transporters to the plasma membrane by guest, on October 30, 2017 www.jlr.org
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Transbilayer Lipid Transporters Daleke 6 may account for the creation of a highly asymmetric plasma membrane from the more symmetric ER and Golgi membranes. Alternatively, lipid randomizing and asymmetry generating lipid transporters may co-exist in multiple membranes, but be differentially regulated. Discrimination between these models awaits the positive identification, verification of intracellular location, and characterization of the biochemical regulation of these transporters.
Maintenance of Plasma Membrane Lipid Asymmetry by Lipid Transporters
Once lipid asymmetry has been established it is maintained by a combination of slow transbilayer diffusion, protein-lipid interactions and protein-mediated transport. The presence of binding sites for acidic lipids, including PS, on the cytoskeletal proteins spectrin and band 4.1(36-38) and soluble membrane-binding proteins such as annexins (39) suggest that cytofacial protein-membrane interactions may play a role in sequestering PS in the cytofacial monolayer. Indeed, lipid-symmetric membranes bind cytoskeletal proteins more poorly than lipid-asymmetric membranes at low ionic strength and have lower mechanical stability (40). However, the number and magnitude of the available binding sites is not sufficient to trap PS (41-44). In addition, spectrin-depleted membranes (45) and pathologic cells with defective or deficient cytoskeletal proteins (46, 47) are capable of generating and maintaining a PS gradient. These data indicate that, although the plastic properties of the erythrocyte membrane require close association with cytofacial lipids, this interaction does not play a major role in the maintenance of lipid asymmetry. Perhaps the most significant contributors to the maintenance and dissipation of transbilayer lipid asymmetry are proteins that catalyze the movement of lipids across the membrane. These activities are classified according to substrate specificity, requirements for energy, and direction of transport ( Figure 1 ). Two classes of transport activities have been described that are responsible for the ATP-dependent transport of lipids. The most well characterized activity is the aminophospholipid translocase or "flippase" which transports PS from the outer monolayer to the cytoplasmic surface of the plasma membrane. A second activity, catalyzed by "floppases," transport lipids in the opposite direction. The most well characterized floppase activities have been shown to catalyze the inner-to-outer monolayer transport of short chain fluorescent lipids and the selective efflux of PC or cholesterol. Three ATP-independent and relatively non-specific scramblase activities have been reported; a plasma membrane Ca 2+ -activated transporter, The ultimate transbilayer distribution of lipids is determined by the specificity of the lipid transporters located in the membrane. Each of the transport activities described above displays a unique specificity or non-specificity that defines its function in the determination of lipid organization. A number of excellent reviews have surveyed this subject recently (17, 18, 20, 54) . The following summarizes the current state of knowledge regarding the specificity of these transport activities and, where evidence is available, the protein(s) involved. Although the transport of these reporter molecules differs somewhat from endogenous lipids, for the most part their movements reflect those of endogenous lipids, at least for aminophospholipid flippase activity. In addition to spin-labeled and fluorescent lipids, native and radiolabeled short (24, 61, 62) The flippase is widely distributed and is present in most plasma membranes.
Flippases
Aminophospholipid flippase activity is ubiquitously expressed in erythrocytes (68) and has been detected in a wide variety of cell types and membranes, including platelets (24, 69), lymphocytes (70) , aortic endothelial cells (71) , fibroblasts (57, 72, 73) , pheochromacytoma cells (74) , hepatocytes (75) , spermatozoa (76) , synaptosomes (77) , and chromaffin granules (78) . Activity is present at both the apical and basolateral surfaces of polarized epithelial cells (79) .
The aminophospholipid flippase is perhaps the most selective of the lipid transporters.
It prefers aminophospholipids over other lipids (24, 55) 2 and the specificity for PS is defined by each of the functional groups of the lipid ( Figure 2 ). The amine group is absolutely required; phosphatidylhydroxypropionate, a PS analog without an amino group, is not a substrate for transport (80). The enzyme can tolerate mono-methylation of PS (80) and, to a limited extent, PE (81). However, progressive methylation of PE reduces transport significantly (81). The carboxyl group is not essential (PE is also a transport substrate), but its absence lowers the rate of transport approximately ten-fold (72, 80) . In contrast to the polar headgroup specificity, the flippase is capable of accepting PS molecules containing fatty acids of various lengths and composition, including spin, fluorescent, and photoactivatable groups (24, 55, 58, 59, 63, (89) (90) (91) , but prefers reporter groups attached to longer acyl chains (58, 59).
The identity of the aminophospholipid flippase remains elusive. Attempts at direct purification of the protein from erythrocytes have yielded preparations with varying characteristics (for review see Daleke & Lyles (92)). However, at least one of these purified candidate erythrocyte flippases (an PS-stimulated Mg 2+ -ATPase) has been reconstituted and demonstrated to transport PS (93).
Another candidate flippase (ATPase II) has been purified and cloned from bovine chromaffin granules (94) (95) (96) . Close homologs of this protein have been identified from bovine brain (97) and human (ATP8A1; (98)) sources. These proteins are members of a new class of P-type ATPases, the P 4 -ATPases (96, 99, 100) . Defects in genes of this family produce alterations in ribosomal assembly (Drs2; (101, 102) ), cold sensitivity in plants (ALA1; (103)), and familial intrahepatic cholestasis (ATP8B1, FIC1; (104)).
Although some controversy exists regarding whether Drs2 is a flippase (102, 105) it is widely believed that the P 4 -ATPase family are lipid transporters. Like the erythrocyte Mg 2+ -ATPase, these enzymes are selectively activated by PS (97, 106) . Recent evidence also indicates that another member of this family (ATP10C) may be associated with Angelman syndrome, a neurological disorder in humans (107), and fat metabolism in mice (108) . Although no direct evidence for transbilayer phospholipid transport has been reported, it is likely that the P 4 -ATPases are involved directly or indirectly in amphipath transport. Whether this activity is involved in the maintenance of transmembrane asymmetry remains to be resolved. The high degree of specificity that the flippase demonstrates for its substrate should enable the eventual positive identification of this protein.
Floppases
The second class of ATP-dependent lipid transporters are the exofacially-directed floppases. Early studies in red blood cells revealed a non-specific outward flux pathway for NBD-and spin-labeled lipids (67, 109) . It was recognized subsequently that some members of the ABC transporter superfamily are capable of transporting lipids (for recent reviews see (18, 19) (110, 111) . ABC transporters are also widely expressed in prokaryotes.
One of these proteins, MsbA, is an inner membrane transporter involved in lipid A export to outer membrane (112) . The ATPase activity of purified MsbA is selectively activated by hexacetylated lipid A (113).
Consistent with their role in general xenobiotic amphipath export, floppase proteins are, for the most part, nonspecific. However, some members of this class demonstrate a unique specificity for their respective substrate. The most well-characterized lipid floppase activities are those catalyzed by ABCA1, ABCB1, ABCB4, and ABCC1.
The ABC transporter ABCA1 (ABC1) has been shown to transport cholesterol out of cells for collection by HDL. ABCA1 is defective in Tangier's disease (114) (115) (116) , an autosomal recessive disorder characterized by low HDL levels and peripheral accumulation of cholesterol. ABCA1 has also been linked to PS efflux (117, 118) and is required for macrophage engulfment of prey in C. elegans (119) . This transporter may act as a floppase for both cholesterol and PS. Whether cholesterol and PS efflux are linked is unclear, but this protein is likely an efflux transporter and is not involved in the maintenance of lipid asymmetry.
ABCB1 (MDR1) is a ubiquitous multidrug resistance xenobiotic transporter and is a lipid transporter of broad specificity. In LLC-PK1 epithelial cells, it catalyzes the efflux of NBD or short chain PC, PE, SM, Glc-Cer, and Gal-Cer (120), but not NBD-PS (121), and may also function to facilitate the movement of platelet activating factor to the cell by guest, on October 30, 2017
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surface (122) . The reconstituted enzyme is similarly non-specific but, in contrast to ABCB1 in situ, also transports NBD-PS (123) . The lack of specificity exhibited by ABCB1 makes it unlikely to be a regulator of transbilayer lipid asymmetry.
ABCB4 (MDR3, mMdr2) is a selective PC transporter (120) . Mice homozygous for a disruption in the mMdr2 gene do not secrete phospholipid into the bile and, as a result, develop liver disease (124) . Secretory vesicles isolated from yeast transfected with mMdr2 are capable of ATP-dependent, vanadate-sensitive uptake of short chain fluorescent PC (125) . Further confirmation of the role of this enzyme as a PC transporter was the demonstration of ATP-dependent PC transport, but not PE transport, in bile canilicular membranes vesicles (126) . In keeping with its role in bile formation, the tissue distribution of ABCB4 is restricted to the liver and bile canilicular membrane (124, 127) . Like ABCA1 and ABCB1, ABCB4 may be involved in lipid efflux, rather than in the maintenance of plasma membrane lipid asymmetry.
ABCC1 (MRP1) was identified initially as a conjugated glutathione transporter (128, 129) . This enzyme was also shown to catalyze the efflux of short chain NBD phospholipid analogs, but not endogenous lipids (such as PS), from the inner to the outer monolayer of the erythrocyte (67, 109, 130, 131) and may account for the previously described efflux activity of these lipids (57, 77) . Cells from an ABCC1 -/-knockout mouse show no efflux of NBD-PC or -PS but possess functional flippase activity (132) . phospholipids (PC and SM), but has no effect on PS or PE distribution (131) . These data indicate that ABCC1 is an outwardly directed PC and sphingolipid-selective transporter.
It is interesting to note that not all ABC lipid transporters are floppases. ABCR is another ABC protein with lipid transport activity although it is a flippase, rather than a floppase. ABCR is present in retinal rod cell outer segment disc membranes and transports N-retinylidene-PE from the disc lumen to the cytofacial side of the membrane (134) . This protein may serve to transport all trans-retinal to the cytoplasm for subsequent export. A deficiency in this gene leads to retinal degeneration (135, 136) .
Scramblases
Rather than assist in the maintenance of lipid asymmetry, scramblases function to degrade transbilayer phospholipid gradients by catalyzing energy-independent bidirectional transbilayer transport. Three scramblase activities have been reported; two are involved in dissipating lipid gradients in biogenic membranes and the third is activated by Ca 2+ in stimulated cells.
The ER scramblase was first described as a bi-directional transporter of PC and its metabolites (28, 137) and has been subsequently shown to be relatively non-specific (29, 138) . Transport activity has been reconstituted from crude (30, 137) and purified (31) ER membrane proteins. The previously described mono-hexosylsphingolipid transporter is also bidirectional and is selective for Glc-Cer or Gal-Cer (34, 35). Evidence has not been found for the activity of these transporters in the plasma membrane. Thus, they may server only to redistribute newly synthesized lipids or lipid precursors in ER and Golgi membranes.
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The Ca 2+ activated scramblase plays an important role in plasma membrane reorganization in response to cell stimulation, such as that accompanying platelet activation and apoptosis. The dissipation of transbilayer asymmetry results in the exposure of PS on the surface of the cell, which activates blood clotting factors (9) and recognition of the cell by macrophages (8, 139, 140) .
Putative scramblases have been purified from erythrocytes (141) and platelets (142) .
The erythrocyte protein (PLSCR1) has been cloned (143) and several additional isoforms have been discovered recently (144) . However, blood cells from a mouse PLSCR1 knockout are not deficient in activation-induced lipid scrambling (145) , suggesting that this protein may not be a scramblase. The presence of potential signaling motifs (146), protein phosphorylation sites (147, 148) , and accumulation in plasma membrane lipid rafts (149) , indicates that this protein may play a role in cellular signaling rather than, or in addition to, its role in lipid randomization.
The Ca 2+ activated scramblase randomizes the distribution of all of the major classes of endogenous (150) and NBD-labeled phospholipids (151) . Recent evidence indicates that the scramblase prefers glycerophospholipids analogs and is sensitive to headgroup size (152) . In general, this transporter is non-selective and serves primarily to express PS on the surface of activated cells.
Conclusion
The interplay between these non-selective and selective transporters results in the maintenance and, in some cases, the generation of transbilayer lipid asymmetry.
Although the tissue distribution and the expression of some of the these transporters is 
